Navin Fluorine Reports Robust Q1 FY27 Growth and Capex Expansion
Navin Fluorine International Ltd 路 Intimation 路 07 Sept 2026, 6:22 pm
Navin Fluorine Reports Robust Q1 FY27 Growth and Capex Expansion Navin Fluorine will interact with investors at the Anand Rathi Summit on 21st Sep'26. In Q1 FY27, consolidated sales grew 44% YoY and 11% QoQ to Rs 1,045.1 Cr, while operating EBITDA surged 73% YoY to Rs 357.1 Cr (34.2% margin). Segment revenues rose YoY across CDMO (+82%), Specialty Chemicals (+48%), and HPP (+33%). The company initiated Phase II cGMP4 capex of Rs 125 Cr (Q4 FY27 commissioning) alongside a Rs 90 Cr Advanced Materials capex (Q2 FY28 commissioning) to drive long-term growth.
Original exchange filing (PDF)
More announcements from Navin Fluorine International Ltd
- Intimation of Schedule of Analyst / Institutional Investor Meets 路 13 Nov 2026
- Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 路 13 Nov 2026
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the officials of Navin Fluorine International Limited .... 路 11 Nov 2026
- Transcript of Earnings Call held for the quarter and half year ended September 30, 2026 路 06 Nov 2026
- Newspaper Advertisement of the financial results for the quarter and half year ended September 30, 2026 路 31 Oct 2026
- Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the audio recording of the Company's .... 路 31 Oct 2026
- Communication to shareholders-Intimation regarding Tax Deduction on Dividend 路 30 Oct 2026
- Investor Presentation for Q2 & H1 of Financial Year 2026-27 路 30 Oct 2026
